Catalyst Pharmaceuticals Inc (CPRX)
14.88
+0.20
(+1.33%)
USD |
NASDAQ |
Apr 26, 16:00
14.88
0.00 (0.00%)
After-Hours: 17:18
Catalyst Pharmaceuticals Price to Book Value: 4.520 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 4.461 |
| April 24, 2024 | 4.594 |
| April 23, 2024 | 4.476 |
| April 22, 2024 | 4.588 |
| April 19, 2024 | 4.598 |
| April 18, 2024 | 4.661 |
| April 17, 2024 | 4.862 |
| April 16, 2024 | 4.722 |
| April 15, 2024 | 4.676 |
| April 12, 2024 | 4.625 |
| April 11, 2024 | 4.804 |
| April 10, 2024 | 4.825 |
| April 09, 2024 | 4.798 |
| April 08, 2024 | 4.713 |
| April 05, 2024 | 4.610 |
| April 04, 2024 | 4.594 |
| April 03, 2024 | 4.707 |
| April 02, 2024 | 4.637 |
| April 01, 2024 | 4.783 |
| March 28, 2024 | 4.844 |
| March 27, 2024 | 4.944 |
| March 26, 2024 | 4.786 |
| March 25, 2024 | 4.819 |
| March 22, 2024 | 4.780 |
| March 21, 2024 | 5.050 |
| Date | Value |
|---|---|
| March 20, 2024 | 5.138 |
| March 19, 2024 | 4.980 |
| March 18, 2024 | 4.886 |
| March 15, 2024 | 4.883 |
| March 14, 2024 | 4.920 |
| March 13, 2024 | 5.050 |
| March 12, 2024 | 4.923 |
| March 11, 2024 | 4.892 |
| March 08, 2024 | 4.938 |
| March 07, 2024 | 5.056 |
| March 06, 2024 | 4.819 |
| March 05, 2024 | 4.944 |
| March 04, 2024 | 5.072 |
| March 01, 2024 | 5.169 |
| February 29, 2024 | 4.871 |
| February 28, 2024 | 4.424 |
| February 27, 2024 | 4.360 |
| February 26, 2024 | 4.309 |
| February 23, 2024 | 4.310 |
| February 22, 2024 | 4.267 |
| February 21, 2024 | 4.208 |
| February 20, 2024 | 4.233 |
| February 16, 2024 | 4.298 |
| February 15, 2024 | 4.264 |
| February 14, 2024 | 4.138 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.965
Minimum
Sep 30 2020
12.28
Maximum
May 06 2019
4.487
Average
4.112
Median
Price to Book Value Benchmarks
| Pfizer Inc | 1.610 |
| Sarepta Therapeutics Inc | 14.06 |
| PTC Therapeutics Inc | -- |
| Corcept Therapeutics Inc | 4.660 |
| Cytokinetics Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 24.39 |
| PS Ratio | 4.184 |
| Price to Free Cash Flow | 26.93 |
| Price | 14.88 |
| Earnings Yield | 4.10% |
| Market Cap | 1.753B |
| Operating PE Ratio | 19.19 |
| Normalized PE Ratio | 24.39 |